Rigid Linker Design Services

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

In PROTAC development, the linker is not simply a passive connector between the target protein ligand and E3 ligase ligand. Its rigidity, length, vector orientation, polarity, and attachment site can determine whether a productive POI-PROTAC-E3 ternary complex is formed, how long the complex remains stable, and whether the degrader achieves selective protein degradation in cellular systems. Rigid linkers, including aromatic, heteroaromatic, alkyne, cycloalkyl, piperazine, triazole, and spirocyclic motifs, are increasingly used to pre-organize PROTAC geometry, reduce conformational entropy loss, and improve structure-activity relationship (SAR) interpretability.

BOC Sciences provides specialized rigid linker design services for PROTAC programs that require conformational control, improved ternary complex geometry, reduced nonspecific flexibility, and data-guided linker optimization. As part of our broader linker design and optimization services, we integrate computational modeling, medicinal chemistry, linker library design, synthesis, analytical characterization, and in vitro degradation evaluation to help pharmaceutical and biotechnology teams identify linker architectures that match their target, E3 ligase, and research objectives.

Request a Consultation Explore Services
Services

BOC Sciences Rigid Linker Design Capabilities

Gene Therapy

Rigid Linker Strategy Design

We analyze the geometry of the POI ligand, E3 ligase ligand, binding vectors, exposed solvent channels, and known SAR constraints to determine whether a rigid, semi-rigid, or hybrid linker strategy is suitable. For early-stage programs, we help clients define linker hypotheses before synthesis, reducing blind linker-length screening and improving decision quality.

Gene Therapy

Rigid Linker Library Construction

BOC Sciences designs and synthesizes focused rigid linker libraries containing phenyl, biphenyl, pyridine, triazole, piperazine, alkyne, cyclopropyl, cyclobutyl, bicyclic, and spirocyclic fragments. For clients requiring ready-to-use building blocks, our PROTAC linker portfolio can support rapid analog generation and customized linker expansion.

Gene Therapy

Linker Vector and Attachment Site Optimization

Rigid linker performance depends strongly on where and how the linker exits both ligands. We evaluate exit vectors, synthetic handles, steric accessibility, and polar group exposure to determine optimal linkage sites. Our team can combine rigid linker design with linker binding site selection and design to improve spatial complementarity between POI and E3 ligase surfaces.

Gene Therapy

Structure-Based PROTAC Modeling

Our modeling team applies molecular docking for protein-ligand, conformational search, ternary complex modeling, and linker pose filtering to prioritize rigid linkers that can orient the two ligands productively. This approach is especially useful when flexible PEG or alkyl linkers produce multiple inactive poses or inconsistent degradation data.

Gene Therapy

Rigid-Flexible Hybrid Linker Optimization

Full rigidity is not always optimal. We design hybrid linkers that combine a conformationally directing rigid motif with limited flexible segments, such as PEG, alkyl, amide, or methylene spacers. This helps balance ternary complex pre-organization, solubility, permeability, synthetic accessibility, and target-dependent conformational tolerance.

Gene Therapy

Synthesis, Characterization, and SAR Iteration

We support synthesis of rigid linker-containing PROTAC analogs, analytical confirmation by LC-MS, HRMS, NMR, and HPLC, and SAR interpretation based on degradation potency, binding behavior, solubility, and stability. The resulting data help clients identify whether linker rigidity improves degradation efficiency or over-constrains productive ternary complex formation.

Need to Move Beyond Empirical Linker Screening?

BOC Sciences helps you design rigid and semi-rigid PROTAC linkers based on target geometry, ternary complex behavior, and SAR data.

Get a Quote

Platforms

Technical Platforms Supporting Rigid Linker Design

Computational Linker Modeling Platform

We use computational approaches to evaluate linker geometry before synthesis, helping teams prioritize rigid linker chemotypes with stronger structural rationale.

  • Protein-ligand docking and exit-vector analysis
  • Ternary complex pose generation and ranking
  • Conformational search of rigid and semi-rigid linkers

Molecular Dynamics and Stability Assessment

For linker candidates requiring deeper analysis, we apply molecular dynamics simulation to evaluate complex stability, linker strain, protein-protein interface persistence, and possible water-mediated interactions.

  • Ternary complex dynamic behavior evaluation
  • Linker conformational strain analysis
  • POI-E3 interface stability comparison

Rigid Linker Chemistry Platform

Our medicinal chemistry team designs and synthesizes rigid linker motifs with tunable geometry, polarity, hydrogen-bonding capacity, and synthetic handles.

  • Triazole, piperazine, phenyl, pyridyl, and alkyne linkers
  • Cycloalkyl, bicyclic, and spirocyclic linker scaffolds
  • Amide, ether, urea, carbamate, and click-compatible handles

Binding and Ternary Complex Evaluation

Rigid linker optimization requires more than binary binding confirmation. We combine binding affinity measurement with ternary complex studies to understand whether a linker improves productive proximity and cooperativity.

  • SPR, BLI, fluorescence-based binding assays
  • POI-PROTAC-E3 ternary complex formation analysis
  • Cooperativity and residence behavior comparison

In Vitro Degradation Validation

We connect linker design hypotheses with functional degradation outcomes through PROTAC in vitro evaluation, helping clients identify rigid linker analogs with meaningful cellular activity.

  • DC50 and Dmax determination
  • Western blot, ELISA, and cellular protein quantification
  • Time-dependent degradation and recovery studies

Developability-Oriented Characterization

Rigid linkers can improve pre-organization but may also affect solubility, permeability, and aggregation tendency. We evaluate key physicochemical properties to support practical degrader optimization.

  • Aqueous solubility and chemical stability assessment
  • Lipophilicity, aggregation, and precipitation risk analysis
  • LC-MS, HRMS, NMR, HPLC, and purity profiling
Advantages

Why Rigid Linkers Matter in PROTAC Design?

Improved Ternary Complex Pre-Organization

Rigid linkers can reduce the conformational freedom of a PROTAC molecule, helping the POI ligand and E3 ligase ligand approach each other with a more favorable spatial orientation.

Clearer SAR Interpretation

Compared with highly flexible linkers, rigid motifs often provide more interpretable SAR because each analog samples fewer conformations, making it easier to connect structure with degradation outcome.

Potential Selectivity Enhancement

By controlling POI-E3 orientation, rigid linkers may help stabilize productive protein-protein contacts that favor selective degradation of specific targets or isoforms.

Reduced Entropic Penalty

Pre-organized linkers can reduce the energetic cost of adopting a productive bound conformation, which may improve ternary complex formation and degradation potency when the geometry is well matched.

Linker Types

Rigid and Semi-Rigid Linker Chemotypes We Design

Aromatic and Heteroaromatic Linkers

Phenyl, biphenyl, pyridyl, pyrimidyl, and other aromatic systems provide directional rigidity and can tune polarity, π-surface exposure, and binding vector geometry. These motifs are useful when a defined linear or angled linker trajectory is required.

Triazole and Click-Derived Linkers

Triazole linkers introduce rigidity, polarity, and hydrogen-bonding potential while providing efficient synthetic accessibility. They are frequently explored when rapid linker analog generation is required across multiple POI and E3 ligand combinations.

Piperazine-Containing Linkers

Piperazine can add conformational restriction and polarity modulation, supporting rigid-flexible hybrid designs. Its local chemical environment must be carefully tuned because substitution patterns can alter basicity, solubility, and cellular performance.

Alkyne and Linear Rigid Linkers

Alkynes provide a compact linear element that can extend linker distance without introducing excessive rotatable bonds. They are often used to test whether a more defined ligand-to-ligand vector improves ternary complex alignment.

Cycloalkyl and Bicyclic Linkers

Cyclopropyl, cyclobutyl, cyclohexyl, bicyclic, and spirocyclic motifs offer three-dimensional rigidity and can help reshape linker topology when flat aromatic systems are not optimal for target geometry or physicochemical balance.

Rigid-Flexible Hybrid Linkers

Hybrid linkers combine rigid direction-setting motifs with short flexible segments to preserve adaptability. This design is valuable when the ternary complex requires both orientation control and limited conformational adjustment.

Workflow

Our Rigid Linker Design Service Workflow

01

Project Consultation and Data Review

We review the POI, E3 ligase, ligand structures, existing linker data, degradation profile, binding information, and project objectives to determine whether rigid linker design is scientifically justified.

02

Binding Vector and Geometry Analysis

Our team evaluates available structures, docking poses, solvent-exposed ligand positions, linker attachment sites, and steric constraints to identify feasible linker trajectories.

03

Rigid Linker Hypothesis Generation

We design multiple linker hypotheses, including fully rigid, semi-rigid, and rigid-flexible hybrid options, with defined rationales for length, angle, polarity, and synthetic accessibility.

04

Computational Prioritization

Candidate linkers are filtered through conformational search, docking, ternary complex modeling, and physicochemical evaluation to prioritize analogs for synthesis.

05

Synthesis of Rigid Linker PROTAC Analogs

Selected analogs are synthesized using suitable coupling, click, amide formation, heterocycle construction, or fragment assembly strategies, followed by analytical confirmation.

06

Binding and Ternary Complex Testing

We evaluate target binding, E3 ligase binding, and POI-PROTAC-E3 ternary complex behavior through appropriate biochemical and biophysical assays, including PROTAC ternary complex assay when required.

07

Functional Degradation Evaluation

Promising analogs are tested in relevant cellular systems to compare degradation potency, Dmax, DC50, time dependence, and concentration-response behavior.

08

SAR Interpretation and Next-Round Design

We integrate modeling, synthesis, binding, degradation, and physicochemical data to recommend the next linker optimization cycle or nominate lead rigid linker candidates.

Start Your Rigid PROTAC Linker Optimization Project

Work with BOC Sciences to transform linker design from trial-and-error into a structure-informed degrader optimization strategy.

Talk to Experts

Why Us

BOC Sciences Advantages in Rigid Linker Design

Integrated PROTAC Expertise

Our team supports PROTAC design services from ligand selection to linker optimization, synthesis, and functional evaluation, allowing rigid linker work to be integrated into the full degrader design process.

Structure-Guided Design Mindset

We do not treat rigid linker design as simple scaffold replacement. Each linker proposal is connected to a specific hypothesis about binding vector, ternary complex geometry, and degradation mechanism.

Diverse Rigid Linker Chemistry

We support aromatic, heteroaromatic, triazole, piperazine, alkyne, cycloalkyl, bicyclic, spirocyclic, and hybrid linker chemotypes, enabling broad exploration of conformationally restricted PROTAC space.

Data-Driven SAR Iteration

Linker analogs are evaluated using binding, degradation, and physicochemical data rather than potency alone, helping clients understand why a rigid linker succeeds or fails.

Physicochemical Balance

We evaluate whether increased rigidity affects solubility, stability, aggregation, and cellular exposure, and can integrate solubility and stability assessment into the linker optimization plan.

Flexible Collaboration Models

Clients may request single-step linker design, focused linker library synthesis, computational prioritization, full PROTAC analog development, or integrated degradation evaluation according to project stage.

Applications

Applications of Rigid Linker Design in PROTAC Programs

Improving Weak or Inconsistent Degradation

When a PROTAC binds both POI and E3 ligase but shows weak degradation, rigid linker design can test whether a more defined spatial arrangement improves productive ternary complex formation.

Optimizing Kinase-Targeting PROTACs

Kinase degraders often require precise positioning to achieve selectivity and strong ternary complex cooperativity. Rigid or semi-rigid linkers can help tune orientation across active and inactive kinase conformations.

Enhancing Selectivity Across Protein Families

Rigid linkers may help discriminate among homologous proteins by stabilizing protein-protein contacts that are favorable for one target but less favorable for related proteins.

Reducing Excessive Linker Flexibility

For PROTACs with long PEG or alkyl linkers, rigid motifs can reduce the number of inactive conformations and help clarify which linker geometry supports degradation.

Building Focused SAR Libraries

Rigid linker motifs allow systematic comparison of linker length, angle, polarity, and exit vector, generating focused SAR libraries with clear design logic.

Supporting Targeted Protein Degradation Tool Development

Rigid linker-containing PROTACs can serve as high-quality chemical biology tools for exploring target dependency, protein function, and ubiquitin-proteasome pathway engagement.

Case Study

Client Success Stories: Rigid Linker Design for PROTACs

Project Background

A biotechnology client was developing a BRD4-targeting PROTAC based on a BET ligand and a VHL ligand. The original analog contained a flexible PEG-alkyl linker and showed measurable BRD4 binding, but cellular degradation was inconsistent across cancer cell models. The client needed a rational linker redesign strategy to improve degradation potency and generate a clearer SAR path.

Technical Challenges

Modeling suggested that the flexible linker sampled multiple inactive poses, and small changes in linker length produced unpredictable degradation outcomes. The client also observed reduced cellular activity for several highly polar linker analogs, indicating that conformational control and physicochemical balance needed to be addressed together.

BOC Sciences Solutions

  • Exit-Vector Analysis: We analyzed available BRD4 and VHL ligand binding modes and identified two solvent-exposed attachment positions suitable for rigid linker introduction.
  • Rigid Linker Library Design: We designed 24 PROTAC analogs using triazole, phenyl-triazole, alkyne-triazole, and semi-rigid PEG-triazole linkers to compare linear, angled, and hybrid trajectories.
  • Computational Prioritization: Ternary complex modeling and conformational strain filtering were used to rank analogs before synthesis, reducing the initial synthesis list to 12 high-priority candidates.
  • Functional Evaluation: The synthesized analogs were tested for BRD4 degradation, DC50, Dmax, and time-dependent degradation behavior in relevant cell lines.

Project Outcomes

BOC Sciences identified a phenyl-triazole hybrid linker analog that achieved stronger BRD4 degradation than the original flexible linker series. Among 12 synthesized candidates, three showed improved degradation profiles, and the lead analog reached low-nanomolar DC50 with higher Dmax and more consistent activity across tested cellular systems. The client obtained a focused SAR map showing that moderate rigidity with one flexible hinge was superior to both fully flexible and fully rigid designs.

Project Background

A pharmaceutical discovery group was optimizing a BTK degrader based on a covalent BTK ligand and a CRBN ligand. The initial PROTAC showed strong BTK engagement but only moderate degradation. The client suspected that linker conformation limited productive POI-E3 proximity and requested a rigid linker redesign campaign.

Technical Challenges

The covalent BTK ligand imposed a constrained attachment vector, while the CRBN ligand tolerated only limited modification. Fully rigid aromatic linkers were predicted to create steric conflict, whereas long flexible linkers reduced SAR clarity and increased aggregation risk.

BOC Sciences Solutions

  • Hybrid Linker Concept: We proposed semi-rigid piperazine-containing linkers with short alkyl spacers to provide directional control without over-constraining the BTK-CRBN complex.
  • Analog Matrix Construction: We designed 18 analogs varying piperazine substitution pattern, spacer length, amide orientation, and polarity distribution.
  • Physicochemical Screening: Solubility, aggregation tendency, and LC-MS stability were evaluated in parallel to avoid selecting linkers that improved binding geometry but compromised cellular performance.
  • Degradation Assay Integration: Lead analogs were tested for BTK degradation, concentration response, and time-course behavior to identify the most productive linker topology.

Project Outcomes

The best semi-rigid piperazine linker analog improved BTK degradation compared with the client's flexible linker reference and showed a clearer concentration-response relationship. Out of 18 designed analogs, five were advanced for synthesis, and two demonstrated improved degradation efficiency. The lead molecule combined a piperazine core with a short methylene spacer, balancing conformational control, solubility, and cellular activity. The client used the resulting SAR package to guide the next round of degrader optimization.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

Rigid linkers are especially valuable when a PROTAC project requires precise control over the spatial orientation between the target protein ligand and the E3 ligase ligand. They are often considered when flexible linkers produce inconsistent degradation, weak ternary complex formation, or poor structure–activity relationships. By reducing excessive conformational freedom, rigid linkers can help improve productive binding geometry and enhance degradation selectivity. BOC Sciences supports rigid linker design by evaluating target topology, ligand exit vectors, E3 ligase selection, linker length, polarity, and synthetic accessibility to build focused linker libraries for systematic optimization.

No. Rigid linkers are not universally superior to flexible linkers. Their main advantage is conformational restriction, which can reduce entropic penalties and favor a productive ternary complex. However, excessive rigidity may prevent the target protein and E3 ligase from adopting the correct proximity or orientation. Flexible linkers may offer broader conformational sampling and improved solubility, but they can also introduce inactive conformations. In many projects, the best solution is a semi-rigid linker strategy that balances structural control, molecular flexibility, physicochemical properties, and degradation performance.

Useful starting information includes the target protein, selected E3 ligase, known target ligand, E3 ligand, proposed attachment sites, preliminary degradation data, cell model, solubility observations, and any available structure–activity relationship data. If clients have molecular docking results, binding-site information, or previous linker screening results, these can further guide linker geometry and length selection. BOC Sciences integrates computational modeling, medicinal chemistry analysis, synthetic feasibility assessment, and functional assay planning to prioritize linker designs that are more likely to support productive ternary complex formation and efficient target degradation.

Rigid linker performance should be assessed through multiple parameters rather than binding affinity alone. Key readouts may include target degradation level, DC50, Dmax, hook effect profile, selectivity, solubility, chemical stability, cell permeability, and overall cellular activity. For the same target protein–E3 ligase pair, BOC Sciences can design a structured linker matrix comparing different aromatic units, alkynyl spacers, cycloalkyl motifs, heterocyclic segments, and semi-rigid hinge structures. These candidates can then be evaluated through in vitro degradation assays, Western blot analysis, cellular activity testing, and LC-MS-based characterization to identify the most promising linker architecture.

BOC Sciences reduces rigid linker optimization risk through an iterative workflow that connects structural hypothesis, focused linker library design, synthesis, functional testing, and data-driven redesign. Instead of replacing linkers mechanically, we design project-specific rigid and semi-rigid structures based on target surface features, ligand exit direction, E3 recruitment requirements, and experimental feedback. For projects with insufficient degradation, poor selectivity, or unbalanced physicochemical properties, we can further adjust linker length, angle, polarity, rigidity, and attachment position. This systematic approach helps clients identify PROTAC candidates with improved degradation activity and development potential.

Testimonials

Client Testimonials on Rigid Linker Design

Clearer Linker SAR

"Our flexible linker series produced confusing degradation results. BOC Sciences helped us design a smaller but more informative rigid linker matrix, and the SAR became much easier to interpret."

— Principal Scientist at a US-based Biotech Firm

Strong Computational Guidance

"The team did not simply suggest common linkers. They connected every rigid linker proposal to a specific ternary complex hypothesis, which helped our internal team make faster design decisions."

— Director of Medicinal Chemistry at a European Pharmaceutical Company

Balanced Chemistry and Biology

"BOC Sciences understood that linker rigidity must be balanced with solubility and cellular performance. Their integrated chemistry and assay support allowed us to identify a practical lead linker."

— Senior Research Manager at an Oncology Discovery Group

Efficient Analog Prioritization

"Instead of synthesizing dozens of random linker analogs, BOC Sciences prioritized a focused set of rigid and semi-rigid designs. This saved resources and gave us actionable degradation data."

— Head of Targeted Protein Degradation at a UK Biotech

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket